Details

Autor(en) / Beteiligte

• LI, SHUAI
• HAN, ZHIYANG
• MA, YONG
• SONG, RUIPENG
• PEI, TIEMIN
• ZHENG, TONGSEN
• WANG, JIABEI
• XU, DONGSHENG
• FANG, XIANG
• JIANG, HONGCHI
• LIU, LIANXIN

Titel

Hydroxytyrosol inhibits cholangiocarcinoma tumor growth: An in vivo and in vitro study

Ist Teil von

• Oncology reports, 2014-01, Vol.31 (1), p.145-152

Ort / Verlag

Greece: D.A. Spandidos

Erscheinungsjahr

2014

Quelle

MEDLINE

Beschreibungen/Notizen

• Cholangiocarcinoma (CCA) is a type of digestive tumor that is associated with a high rate of mortality due to the difficulty of early diagnosis and the resistance of this tumor type to chemotherapy. Hydroxytyrosol (HT), which is derived from virgin olive oil (VOO), has recently been reported to inhibit the proliferation of various types of human cancer cells. In the present study, we investigated the effect of HT on CCA. The antiproliferative and proapoptotic effects of HT on CCA were evaluated in the human CCA cell lines TFK-1 and KMBC and the human gallbladder cancer cell line GBS-SD. We also assessed this effect in vivo. We found that 75 μM HT inhibited the proliferation of the TFK-1, KMBC and GBS-SD cell lines. However, 200 μM HT treatment did not affect the proliferation of the human bile duct cell line HIBEpiC. More importantly, HT (250 and 500 mg/kg/day) markedly inhibited the growth of CCA xenografts in mice. G2/M phase cell cycle arrest and apoptosis were observed using flow cytometry and western blotting, and we also noted a time- and dose-dependent inhibition of phospho-ERK, with no changes in total-ERK, during treatment with HT. The present study showed that HT induces cell cycle arrest and apoptosis in vitro and in vivo. These data suggest that HT, which possesses excellent biocompatibility and few side-effects, could be developed as a novel agent against CCA.